Equities research analysts forecast that Cardinal Health Inc (NYSE:CAH) will report $1.10 earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Seven analysts have provided estimates for Cardinal Health’s earnings. The highest EPS estimate is $1.23 and the lowest is $1.01. Cardinal Health posted earnings per share of $1.09 during the same quarter last year, which would suggest a positive year-over-year growth rate of 0.9%. The business is expected to announce its next earnings report on Monday, November 5th.

According to Zacks, analysts expect that Cardinal Health will report full-year earnings of $5.04 per share for the current year, with EPS estimates ranging from $4.98 to $5.15. For the next year, analysts expect that the company will post earnings of $5.43 per share, with EPS estimates ranging from $5.27 to $5.55. Zacks Investment Research’s EPS averages are an average based on a survey of research firms that that provide coverage for Cardinal Health.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Monday, August 6th. The company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.93 by $0.08. The company had revenue of $35.35 billion for the quarter, compared to analyst estimates of $34.38 billion. Cardinal Health had a net margin of 0.19% and a return on equity of 22.59%. The firm’s revenue was up 7.2% on a year-over-year basis. During the same period in the previous year, the firm posted $1.31 EPS.

CAH has been the topic of several research reports. Leerink Swann raised shares of Cardinal Health from a “market perform” rating to an “outperform” rating and set a $75.00 price target on the stock in a report on Tuesday, April 24th. Royal Bank of Canada set a $81.00 target price on shares of Cardinal Health and gave the stock a “hold” rating in a research report on Tuesday, April 24th. Zacks Investment Research upgraded shares of Cardinal Health from a “sell” rating to a “hold” rating in a research report on Wednesday, April 25th. ValuEngine downgraded shares of Cardinal Health from a “hold” rating to a “sell” rating in a research report on Wednesday, May 2nd. Finally, Jefferies Financial Group set a $55.00 target price on shares of Cardinal Health and gave the stock a “hold” rating in a research report on Friday, May 4th. Three analysts have rated the stock with a sell rating, nine have given a hold rating and three have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $62.00.

Shares of Cardinal Health stock traded up $1.45 during midday trading on Monday, hitting $51.90. 4,880,659 shares of the company traded hands, compared to its average volume of 3,318,766. The firm has a market capitalization of $15.04 billion, a PE ratio of 10.38, a price-to-earnings-growth ratio of 1.78 and a beta of 0.99. The company has a current ratio of 1.07, a quick ratio of 0.53 and a debt-to-equity ratio of 1.32. Cardinal Health has a 12 month low of $48.14 and a 12 month high of $75.75.

The firm also recently announced a quarterly dividend, which will be paid on Monday, October 15th. Investors of record on Monday, October 1st will be given a dividend of $0.4763 per share. The ex-dividend date is Friday, September 28th. This is an increase from Cardinal Health’s previous quarterly dividend of $0.48. This represents a $1.91 annualized dividend and a yield of 3.67%. Cardinal Health’s dividend payout ratio (DPR) is currently 38.20%.

A number of large investors have recently bought and sold shares of the stock. Deprince Race & Zollo Inc. lifted its position in shares of Cardinal Health by 11.0% in the 2nd quarter. Deprince Race & Zollo Inc. now owns 441,884 shares of the company’s stock worth $21,577,000 after purchasing an additional 43,672 shares during the period. Parsons Capital Management Inc. RI acquired a new position in shares of Cardinal Health in the 1st quarter worth approximately $201,000. Russell Investments Group Ltd. lifted its position in shares of Cardinal Health by 103.7% in the 1st quarter. Russell Investments Group Ltd. now owns 1,280,457 shares of the company’s stock worth $80,241,000 after purchasing an additional 651,833 shares during the period. Knights of Columbus Asset Advisors LLC lifted its position in shares of Cardinal Health by 15.0% in the 1st quarter. Knights of Columbus Asset Advisors LLC now owns 10,729 shares of the company’s stock worth $672,000 after purchasing an additional 1,400 shares during the period. Finally, Artisan Partners Limited Partnership lifted its position in shares of Cardinal Health by 1.2% in the 1st quarter. Artisan Partners Limited Partnership now owns 783,136 shares of the company’s stock worth $49,087,000 after purchasing an additional 9,639 shares during the period. Institutional investors and hedge funds own 89.98% of the company’s stock.

About Cardinal Health

Cardinal Health, Inc operates as an integrated healthcare services and products company worldwide. The company's Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare, and consumer products to retailers, hospitals, and other healthcare providers.

Further Reading: Marijuana Stocks Investing Considerations

Get a free copy of the Zacks research report on Cardinal Health (CAH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.